Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Mapk9
REST API REST API
Rattus norvegicus
Mapk9 is differentially expressed in 75 experiments: 58 organism parts: hippocampus, frontal cortex, ... (56 more);, 8 disease states: normal, bone fracture, ... (6 more);, 14 cell types 11 compound treatments 7 clinical treatments and 13 other conditions.
Synonyms SAPK
Orthologs HOG1 (Saccharomyces cerevisiae)   Q4H3A2_CIOIN (Ciona intestinalis)   Mapk9 (Mus musculus)   MAPK9 (Homo sapiens)   MK09_CHICK (Gallus gallus)   (Compare orthologs)
Gene Ontology Term cytosol, regulation of JNK cascade, positive regulation of caspase activity, JUN kinase activity, positive regulation of nitric oxide biosynthetic process, protein binding, JUN phosphorylation, cytoplasm, response to toxin, positive regulation of gene expression, protein targeting to mitochondrion, activation of caspase activity, MAP kinase activity, positive regulation of apoptosis, transcription factor binding, response to cadmium ion, ATP binding, transferase activity, transferring phosphorus-containing groups, neuron projection development, nucleus, caspase activator activity, nucleotide binding, protein serine/threonine kinase activity, response to drug, JNK cascade, transferase activity, regulation of protein ubiquitination, positive regulation of transcription, DNA-dependent, response to mechanical stimulus, protein kinase activity, central nervous system development, mitochondrion, positive regulation of prostaglandin secretion, positive regulation of macrophage derived foam cell differentiation, response to amine stimulus, positive regulation of cell morphogenesis involved in differentiation, cellular response to tumor necrosis factor, release of cytochrome c from mitochondria, cellular response to UV, cytosolic part, positive regulation of prostaglandin biosynthetic process, response to organic substance, induction of apoptosis in response to chemical stimulus, cellular response to lipopolysaccharide, positive regulation of chemokine production, mitogen-activated protein kinase kinase kinase binding, cellular response to interleukin-1, protein phosphorylation, positive regulation of protein phosphorylation
InterPro Term Se/Thr_prot_kinase-like_dom, Kinase-like_dom, Ser/Thr_prot_kinase_dom, Prot_kinase_cat_dom, MAP_kinase_CS, Tyr_Pkinase_cat_dom, Ser/Thr_prot_kinase_AS, JNK_MAPK, Ser-Thr/Tyr-Pkinase
UniProt Accession P49186, Q6P727, D4A5V8
Search EB-eye ENSRNOG00000002823
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-3309, E-GEOD-19830, E-GEOD-2354, E-GEOD-20388, E-AFMX-7, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-GEOD-5940, E-MEXP-31, E-GEOD-1567, E-GEOD-2499, E-TABM-130, ... (6 experiments)

Factor Value U/D Experiments
Sertoli cell
1
2
E-TABM-130, E-MEXP-31
1
E-TABM-130
spermatogonia
1
E-MEXP-31
oligodendrocyte
1
E-GEOD-5940
spermatogonium
1
E-TABM-130
myoctye
1
1
E-GEOD-2032
8 more value(s).


Disease state

studied in E-GEOD-1872, E-MEXP-1025, E-GEOD-594, E-GEOD-464

Factor Value U/D Experiments
severe spinal cord injury
1
E-GEOD-464
bone fracture
1
1
E-GEOD-594
mild spinal cord injury
1
1
E-GEOD-464
moderate spinal cord injury
2
1
E-GEOD-464
experimental autoimmune encephalomyelitis (acute)
1
1
E-MEXP-1025
experimental autoimmune encephalomyelitis (recovery)
1
1
E-MEXP-1025
2 more value(s).


Compound treatment

studied in E-GEOD-2602, E-GEOD-487, E-GEOD-2303, E-MEXP-782, E-GEOD-22647 ... (5 experiments)

Factor Value U/D Experiments
none
4
E-GEOD-2303, E-GEOD-487, E-MEXP-782, E-GEOD-2602
ponasterone
1
E-GEOD-2602
methylprednisolone
3
1
E-GEOD-487
vehicle
1
E-GEOD-22647
diethylhexylphthalate
1
1
E-GEOD-2303
AICAR
1
E-GEOD-22647
5 more value(s).


Clinical treatment

studied in E-MEXP-976, E-GEOD-7002, E-GEOD-738, E-MTAB-104

Factor Value U/D Experiments
aortic banding
1
1
E-GEOD-738
sham surgery
3
1
E-MEXP-976
spinal nerve transection
1
E-MEXP-976
instillation
1
E-GEOD-7002
none
5
1
E-GEOD-738
no implantation
1
E-MTAB-104
1 more value(s).


Cohort

studied in E-GEOD-20388

Factor Value U/D Experiments
Cohort 1
1
E-GEOD-20388
Cohort 2
1
E-GEOD-20388


compound_treatment_design
studied in E-TABM-12

Day
studied in E-GEOD-20659

Developmental stage
studied in E-GEOD-4236, E-GEOD-903

Genetic modification
studied in E-GEOD-2602, E-GEOD-6428

Growth condition
studied in E-GEOD-1567

Material type
studied in E-GEOD-4192, E-GEOD-467, E-MEXP-2527

Phenotype
studied in E-GEOD-3531

protocol
studied in E-GEOD-20895

Protocol type
studied in E-GEOD-691, E-GEOD-1139, E-MEXP-1565

Replicate
studied in E-GEOD-4192

Strain or line
studied in E-MEXP-776, E-TABM-197, E-MTAB-322, E-TABM-457, E-GEOD-952, ... (7 experiments)

Treatment
studied in E-GEOD-16981, E-GEOD-19909

Processing time: 0.134 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM